{"database": "openregs", "table": "dockets", "rows": [["FDA-2026-N-10505", "FDA", "FHTA LLC; Withdrawal of Approval of New Drug Application for Mysoline (Primidone) Suspension, 250 Milligrams/5 Milliliters", "Nonrulemaking", "2026-09-29T13:09:01Z", "0b000064b94f9e9e", null, null, null, null, null, null, null, null, null, null, "list_pull"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id", "rin", "dkabstract", "category", "subtype", "keywords", "program", "short_title", "effective_date", "organization", "attrs_raw", "attr_source"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-N-10505"], "units": {}, "query_ms": 0.18601799092721194, "source": "U.S. government sources, plus a few identifier registries; each is listed on the methodology page", "source_url": "https://datadawn.org/methodology#data", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}